347850.KQ
347850.KQ
KR7347850000
D&D Pharmatech
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.96T EUR
4.05T EUR
3.3T EUR
4T EUR
Enterprise Value
1.85T EUR
4.15T EUR
3.28T EUR
3.97T EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
--
--
--
--
Price to Sales
714.12x
1,471.59x
1,094.77x
1,385.7x
Price to Book
--
30.04x
44.25x
50.27x
EV/Revenue
673.77x
1,508.98x
1,088.6x
1,376.46x
EV/EBITDA
-57.98x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-2.05%
-0.62%
-0.76%
-0.38%
ende